News

Relativity Announces Expansions to Relativity aiR, its Suite of Generative AI Solutions, at Legalweek 2024

January 30, 2024 01:00 AM AEDT| By Cision

CHICAGO, Jan. 29, 2024 /PRNewswire/ -- Relativity, a global legal technology company, kicks off Legalweek 2024 announcing the limited availability launch of Relativity aiR for Review ...

Lifelong Learner Holdings announces the sale of PSI Services

January 30, 2024 01:00 AM AEDT| By Cision

LLH tightens strategic focus on Talogy, the expert talent management solutions provider. GLENDALE, Calif., Jan. 29, 2024 /PRNewswire/ -- Lifelong Learner Holdings LLC (LLH) today announce...

Brands Need to Embrace and Support Today's Customer Experience Economy, Findings Detailed in the 2024 Merkle Customer Experience Imperatives

January 30, 2024 01:00 AM AEDT| By Cision

Global research offers insights into how consumers engage with and experience brands. COLUMBIA, Md., Jan. 29, 2024 /PRNewswire/ -- Merkle, dentsu's leading technology-enabled, data-driven...

E-Home Household Services Holdings Limited and Xiamen Iron Meal Enterprise Management Co., Ltd. signed an agreement on cleaning services for high-speed railway trains, with a total amount of more than RMB 8 million.

January 30, 2024 01:00 AM AEDT| By Cision

FUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider in China, the...

Octoparse Releases New Contact Details Scraper for Leads Web Scraping

January 30, 2024 01:00 AM AEDT| By Cision

LOS ANGELES, Jan. 29, 2024 /PRNewswire/ -- Octoparse, a no-coding solution for web scraping to turn pages into structured data within clicks, makes bulk-extracting of data further accessible. Wit...

OLIGHT Shines Bright at SHOT Show 2024: A Recap of Innovation and Super Customer Service

January 30, 2024 12:55 AM AEDT| By Cision

LAS VEGAS, Jan. 29, 2024 /PRNewswire/ -- OLIGHT, a leader in the portable lighting industry, proudly announces its successful participation at the Shooting, Hunting, Outdoor Trade Show (SHOT Show...

AV-Comparatives Names Consumer Product of The Year in Summary Report 2023

January 30, 2024 12:51 AM AEDT| By Cision

INNSBRUCK, Austria, Jan. 29, 2024 /PRNewswire/ -- AV-Comparatives awards Kaspersky as Product of the Year 2023. Bitdefender awarded as Outstanding and Avast, AVG, Avira, ESET and G Data win Top...

The Wall Street Journal Names Merck Among Top 10 Best-Managed Companies

January 30, 2024 12:30 AM AEDT| By 3BL

Our company has been recognized for our leadership and strong performance powering the work we do for patients and everyone who depends on us. We were named No. 10 on The Wall Street Journal’s list of...

Vesicure Therapeutics made notable advancements using exosomes to target KRAS mutation

January 30, 2024 12:30 AM AEDT| By Cision

SUZHOU, China, Jan. 29, 2024 /PRNewswire/ -- SiRNA technology offers distinct advantages over conventional approaches, with the potential to target virtually any gene. This technology has...

Lion's OTC Options Services Grows Significantly, Unlocking New Territory for Its Brokerage Business

January 30, 2024 12:30 AM AEDT| By Cision

HONG KONG, Jan. 29, 2024 /PRNewswire/ -- Lion Group Holding Ltd. ("Lion" or "the Company") (NASDAQ: LGHL), operator of an all-in-one trading platform that offers a wide spectr...

KOCH INVESTS: Building an Energy-Efficient Recycling Steel Rebar Mill

January 30, 2024 12:25 AM AEDT| By 3BL

Koch Minerals & Trading (KM&T) recently participated in a $700 million debt and equity financing round for Hybar, a newly formed company that plans to build, start up and operate a technologic...

JETOUR T2 Debuts in the UAE, Featuring Advanced XWD Technology

January 30, 2024 12:20 AM AEDT| By Cision

DUBAI, UAE, Jan. 29, 2024 /PRNewswire/ -- On January 27th, 2024, JETOUR T2 was officially launched in Dubai, United Arab Emirates, marking the beginning of its international journey. At the event,...

$Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.$

Oricell Announces FDA Clearance of IND Application for OriCAR-017, a novel GPRC5D Targeted CAR-T Cell Therapy Utilizing the Company's Proprietary Platform, for the Treatment of Relapsed/Refractory Multiple Myeloma.

January 30, 2024 12:08 AM AEDT| By Cision

SHANGHAI and ROSELAND, N.J., Jan. 29, 2024 /PRNewswire/ -- Oricell Therapeutics (Oricell), a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FD...